TAK logo

TAK Cost of Revenue

Latest reported¥406.68B JPY
TAK Quarterly Cost of Revenue · JPY (¥72.08B → ¥406.68B)
High-resolution chart · PNG

TAK cost of revenue history

Quarterly · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) Cost of Revenue — Quarterly (JPY)
Period endingCost of Revenue (JPY)
406,676,000,000
570,838,752,000
552,865,714,000
380,061,000,000
384,675,000,000
382,100,000,000
416,874,000,000
394,311,000,000
386,954,000,000
387,328,000,000
379,481,000,000
343,582,000,000
321,114,000,000
309,772,000,000
335,973,000,000
305,445,000,000
292,882,000,000
308,380,000,000
281,404,000,000
275,797,000,000
241,264,000,000
253,446,000,000
253,142,000,000
249,642,000,000
238,078,000,000
248,181,000,000
279,575,000,000
271,710,000,000
300,592,000,000
289,835,000,000
138,514,000,000
110,751,000,000
120,590,000,000
110,892,000,000
142,287,000,000
121,873,000,000
120,868,000,000
134,407,000,000
147,490,000,000
141,462,000,000
135,395,000,000
132,965,000,000
145,026,000,000
136,293,000,000
121,121,000,000
134,583,000,000
139,420,000,000
128,948,000,000
118,039,000,000
130,943,000,000
131,537,000,000
120,137,000,000
115,091,000,000
111,072,000,000
120,496,000,000
112,747,000,000
103,313,000,000
128,175,000,000
145,454,000,000
80,665,000,000
78,900,000,000
82,887,000,000
84,112,000,000
77,481,000,000
73,102,000,000
70,435,000,000
74,248,000,000
69,046,000,000
71,336,000,000
68,273,000,000
70,562,000,000
72,081,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.